Consolidated Balance Sheet as at March 31, 2025 (` cr) Particulars Note As at March 31, 2025 As at March 31, 2024 A ASSETS 1. Non-current assets a) Property, plant and equipment 2 2,791.98 2,737.09 b) Capital work-in-progress 2 124.33 280.75 c) Investment properties 3 3.22 3.22 d) Goodwill 4 29.14 29.14 e) Other intangible assets 4 1.60 1.73 f) Biological assets other than bearer plants 5 21.40 21.00 g) Investments accounted for using the equity method 6.1 57.10 49.58 h) Financial assets i) Investments 6.2 892.58 916.09 ii) Loans 7 0.41 0.26 iii) Other financial assets 8 17.28 10.29 i) Income tax assets (net) 30.5 2.63 5.04 j) Deferred tax assets (net) 30.5 21.41 21.25 k) Other non-current assets 9 93.04 125.23 Total non-current assets 4,056.12 4,200.67 2. Current assets a) Inventories 10 729.29 618.26 b) Biological assets other than bearer plants 5 35.78 32.12 c) Financial assets i) Investments 6.3 816.27 426.40 ii) Trade receivables 11 1,126.26 927.04 iii) Cash and cash equivalents 12 51.37 60.26 iv) Bank balances other than (iii) above 13 13.29 12.04 v) Other financial assets 8 21.75 22.22 d) Other current assets 9 150.86 177.27 Total current assets 2,944.87 2,275.61 Total assets 7,000.99 6,476.28 B EQUITY AND LIABILITIES Equity a) Equity share capital 14 29.46 29.46 b) Other equity 15 5,569.09 5,084.88 Equity attributable to owners of the Company 5,598.55 5,114.34 Non-controlling interests 63.82 49.05 Total equity 5,662.37 5,163.39 Liabilities 1. Non-current liabilities a) Financial liabilities i) Borrowings 16 182.01 209.30 ii) Lease liabilities 30.12 4.04 4.70 iii) Other financial liabilities 17 5.72 4.22 b) Provisions 18 36.80 31.12 c) Deferred tax liabilities (net) 30.5 225.33 174.15 d) Other non-current liabilities 19 0.94 0.99 Total non-current liabilities 454.84 424.48 2. Current liabilities a) Financial liabilities i) Borrowings 16 15.68 22.55 ii) Trade payables 20 Total outstanding dues of a) Micro-enterprises and small enterprises 38.39 58.37 b) Creditors other than micro-enterprises and small enterprises 576.31 520.94 iii) Other financial liabilities 17 179.74 215.35 b) Contract liabilities 21 33.16 37.84 c) Other current liabilities 19 14.23 12.09 d) Provisions 18 21.03 21.04 e) Current tax liabilities (net) 30.5 5.24 0.23 Total current liabilities 883.78 888.41 Total liabilities 1,338.62 1,312.89 Total equity and liabilities 7,000.99 6,476.28 The accompanying Notes 1-30 form an integral part of the Consolidated Financial Statements. In terms of our report attached For Deloitte Haskins & Sells LLP For and on behalf of the Board of Directors Chartered Accountants Gopi Kannan Thirukonda Pradeep Banerjee Sunil Lalbhai Ketan Vora (DIN:00048645) (DIN:02985965) (DIN:00045590) Partner Whole-time Director and CFO Chairman and Managing Director Membership No:100459 Rangaswamy Iyer Lalit Patni (DIN:00474407) Samveg Lalbhai Company Secretary (DIN:00009278) Sharadchandra Abhyankar Managing Director Bharathy Mohanan (DIN: 00108866) (DIN:00198716) Whole-time Director Sujal Shah and President - U&S (DIN: 00058019) Vivek Gadre Praveen Kadle (DIN:08906935) (DIN: 00016814) Whole-time Director Padmaja Chunduru Mumbai (DIN: 08058663) Mumbai April 25, 2025 Directors April 25, 2025 234 234 Integrated Annual Report 2024-25
RkJQdWJsaXNoZXIy MjA2MDI2